Larry E. Romrell - 06 Dec 2021 Form 4 Insider Report for Qurate Retail, Inc. (QVCGA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Dec 2021, 16:13:32 UTC
Prior SEC filing
21 Jun 2021
Next SEC filing
09 Dec 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brittany A. Uthoff as Attorney-in-Fact for Larry E. Romrell

Key filing fact

Larry E. Romrell filed Form 4 for Qurate Retail, Inc. (QVCGA) on 08 Dec 2021.

Key facts

  • This page summarizes Larry E. Romrell's Form 4 filing for Qurate Retail, Inc. (QVCGA).
  • 1 reported transaction and 7 derivative rows are listed below.
  • Accepted by SEC: 08 Dec 2021, 16:13.

Change

  • Previous filing in this sequence was filed on 21 Jun 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QRTEA transaction Derivative

Restricted Stock Units - QRTEA

Award

Transaction value
$0
Shares
+14,188
Change %
Price
$0.000000
Shares after
14,188
Date
06 Dec 2021
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
14,188
Exercise price
Footnotes
F1
QRTEA holding Derivative

Stock Option (right to buy) - QRTEA

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
82,297
Date
06 Dec 2021
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
82,297
Exercise price
$4.21
Footnotes
F2, F3
QRTEA holding Derivative

Stock Option (right to buy) - QRTEA

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
27,198
Date
06 Dec 2021
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
27,198
Exercise price
$8.84
Footnotes
F4
QRTEA holding Derivative

Stock Option (right to buy) - QRTEA

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
32,460
Date
06 Dec 2021
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
32,460
Exercise price
$10.80
Footnotes
F3, F5
QRTEA holding Derivative

Stock Option (right to buy) - QRTEA

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
26,897
Date
06 Dec 2021
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
26,897
Exercise price
$11.50
Footnotes
F3, F6
QRTEA holding Derivative

Stock Option (right to buy) - QRTEA

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,597
Date
06 Dec 2021
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
21,597
Exercise price
$11.85
Footnotes
F3, F7
QRTEA holding Derivative

Stock Option (right to buy) - QRTEA

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
19,236
Date
06 Dec 2021
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
19,236
Exercise price
$12.82
Footnotes
F3, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Series A Common Stock.

Footnote F2

On November 4, 2021, the Issuer announced that its board of directors declared a special cash dividend in the amount of $1.25 per common share payable on November 22, 2021, to all holders of record of the Issuer's common stock at the close of business on November 15, 2021 (the "Dividend"). This stock option award was previously reported as an option relating to 70,209 shares of the Issuer's Series A common stock at an exercise price of $4.92 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended ("Rule 16b-3").

Footnote F3

The derivative security is fully vested.

Footnote F4

This stock option award was previously reported as an option relating to 24,726 shares of the Issuer's Series A common stock at an exercise price of $10.34 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F5

This stock option award was previously reported as an option relating to 27,746 shares of the Issuer's Series A common stock at an exercise price of $12.64 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F6

This stock option award was previously reported as an option relating to 22,984 shares of the Issuer's Series A common stock at an exercise price of $13.46 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F7

This stock option award was previously reported as an option relating to 18,453 shares of the Issuer's Series A common stock at an exercise price of $13.87 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.

Footnote F8

This stock option award was previously reported as an option relating to 16,454 shares of the Issuer's Series A common stock at an exercise price of $15.00 per share and was adjusted as a result of the Dividend. In connection with the Dividend, all common stock options held by the reporting person were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the reporting person received an adjustment to (i) the exercise price and (ii) the number of shares relating to such option. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3.

SEC remarks

Exhibit List: Ex. 24 - Power of Attorney.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .